Trial Profile
A Phase I, Open-Label, Randomized, Crossover Trial in 20 Healthy Subjects to Investigate the Pharmacokinetic Interactions Between the Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Dec 2009
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Efavirenz; Tenofovir disoproxil fumarate
- Indications Hepatitis C; HIV infections
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 16 Jun 2009 Actual end date (April 2009) added as reported by ClinicalTrials.gov.
- 16 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Feb 2009 Additional location identified as reported by ClinicalTrials.gov, last updated 27-2-2009.